Adagene Inc. (ADAG)
NASDAQ: ADAG · Real-Time Price · USD
1.520
-0.035 (-2.25%)
Mar 31, 2025, 2:23 PM EDT - Market open
Adagene Market Cap
Adagene has a market cap or net worth of $71.61 million as of March 31, 2025. Its market cap has decreased by -42.65% in one year.
Market Cap
71.61M
Enterprise Value
6.32M
1-Year Change
-42.65%
Ranking
Category
Stock Price
$1.52
Market Cap Chart
Since the IPO on February 9, 2021, Adagene's market cap has decreased from $804.22M to $71.61M, a decrease of -91.10%. That is a compound annual growth rate of -44.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 73.26M | -16.85% |
| Dec 31, 2024 | 88.10M | 4.06% |
| Dec 29, 2023 | 84.66M | 47.15% |
| Dec 30, 2022 | 57.54M | -83.64% |
| Dec 31, 2021 | 351.59M | -56.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |